OncoMatch/Clinical Trials/NCT07884474
Feasibility and Acceptability of Remote Saliva Collection
Is NCT07884474 recruiting? Yes, currently enrolling (Oct 2026).
The purpose of this study is to evaluate the practicality and acceptability of collecting biological samples and health information from childhood survivors of acute lymphoblastic leukemia (ALL) and their siblings. Participants will provide saliva, blood, hair, and fingernail samples, complete questionnaires, and participate in sleep monitoring. The information collected will help researchers understand how cancer treatment and neighborhood conditions may affect stress hormones, inflammation, and long-term health. Primary Objective \- To evaluate the feasibility of collecting multiple biological specimens, surveys, and sleep assessment among child and adolescent survivors of ALL and their siblings.
Check if I qualifyExtracted eligibility criteria
Cancer type
Acute Lymphoblastic Leukemia
Non-Hodgkin Lymphoma
Demographics
Prior therapy
Cannot have received: cranial therapy as part of ALL therapy
The survivor did not receive cranial therapy as part of ALL therapy.
Cannot have received: prolonged steroid medications or systemic glucocorticoids for reasons other than ALL
Survivor and/or sibling has a history of prolonged treatment with steroid medications or systemic glucocorticoids for reasons other than ALL.
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- St. Jude Children's Research Hospital · Memphis, Tennessee
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT07884474 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior cranial therapy as part of ALL therapy, prolonged steroid medications or systemic glucocorticoids for reasons other than ALL disqualifies patients from enrollment.
Is there an age limit?
Yes. Patients must be 18 years or younger and at least 8 years old.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify